Other lipid agents × glycemic control

TrialLipids in health and disease2015

A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia.

Itori Saito et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 152 people · 2015

Range includes no effect

No clear effect on glycemic control

+0.08−0.07 to +0.23

As reported

difference 0.08, 95% CI −0.07 to 0.23

+2 more in the walkthrough ↓

Three numbers in the abstract

the abstract, start to end

levels (between-treatment differences 0.00 [95% CI: -0.47, 0.47]) and fasting plasma glucose (between-treatment differences -4.8 [95% CI: -12.1, 2.1]) were

groups (between-treatment difference 0.08 [95% CI: -0.07 to 0.23]).

← favours treatmentfavours comparator →
could be chance
Glycemic control
0.00−0.47 to 0.47
Glycemic control
0.08−0.07 to 0.23
Glycemic control
−4.8−12.1 to 2.10
Other lipid agentsDiet, exercise & lifestyleGlycemic control

Other lipid agents × glycemic controlhelps?mixed

unlikelylikely
0.400.40 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 6

6 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 25929253